Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients.
Slavin
Shimon
S
Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, Jerusalem, Israel.
D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017710:Lymphocyte Transfusion; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous